Details of the Drug | DrugMAP

General Information of Drug (ID: DMIW5P1)

Drug Name

BPM 31510

Indication

Disease Entry	ICD 11	Status	REF
Glioma	2A00.0	Phase 2	[1]
Pancreatic cancer	2C10	Phase 2	[2]
Epidermolysis bullosa	EC3Z	Phase 1	[3]
------------------------------------------------------------------------------------

Drug Type

Lipid-drug conjugate

Cross-matching ID

TTD ID: D4MZR2

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT04752813) A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02650804) A Phase 2 Study of BPM31510 (Ubidecarenone, USP) Nanosuspension Injection Administered Intravenously With Gemcitabine as 2nd/3rdline Therapy in Advanced Pancreatic Cancer Patients. U.S.National Institutes of Health.
3	ClinicalTrials.gov (NCT02793960) Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa. U.S. National Institutes of Health.